or Try an Advanced Search...

    Hematologic Malignancies Stocks List

    Symbol Grade Name % Change
    TCRX A TScan Therapeutics, Inc. 1.65
    SLS A SELLAS Life Sciences Group, Inc. -5.52
    PRTC A PureTech Health plc 5.09
    HOWL B Werewolf Therapeutics, Inc. -0.78
    KYMR C Kymera Therapeutics, Inc. -1.40
    INMB C INmune Bio Inc. 4.73
    CLLS D Cellectis S.A. -4.57
    FATE D Fate Therapeutics, Inc. -5.29
    CRBU F Caribou Biosciences, Inc. -3.27
    AFMD F Affimed Therapeutics B.V. -8.79
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Solid Tumors Cancer Biotechnology Life Sciences Medicine Tumors Of The Hematopoietic And Lymphoid Tissues CD19 Clinical Medicine Immune System Immunology Acute Myeloid Leukemia Biology Blastoma Cancer Immunotherapy Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Health Sciences Hematopoietic Stem Cell

    Related ETFs - A few ETFs which own one or more of the above listed Hematologic Malignancies stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 7.52
    WDNA D WisdomTree BioRevolution Fund 3.36
    CNCR D Loncar Cancer Immunotherapy ETF 3.21
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.65
    XBI D SPDR S&P Biotech ETF 1.63
    View all Hematologic Malignancies ETFs...
    Compare ETFs
    Compare SURI to BBC Compare SURI to WDNA Compare WDNA to BBC

        Hematologic Malignancies Stocks Recent News

        Date Stock Title
        Apr 24 TCRX TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
        Apr 24 TCRX TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
        Apr 24 HOWL Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 CRBU Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 AFMD Wall Street Analysts Believe Affimed N.V. (AFMD) Could Rally 146.73%: Here's is How to Trade
        Apr 24 AFMD Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
        Apr 23 HOWL Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
        Apr 22 TCRX TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
        Apr 22 FATE Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
        Apr 22 CLLS Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
        Apr 22 INMB INmune Bio rises 2%, on $4.5M direct offering
        Apr 22 INMB INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering
        Apr 22 INMB INmune Bio: An Opportunity In The Freefall (Rating Upgrade)
        Apr 19 SLS Sellas Life Sciences Group: A Lottery Ticket With An Estimated 9x Payout
        Apr 19 TCRX TScan Therapeutics Announces Closing of Upsized Public Offering
        Apr 18 FATE Fate Therapeutics files to sell 3.64M shares for holders
        Apr 18 CRBU Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Solid Tumors Cancer Biotechnology Life Sciences Medicine Tumors Of The Hematopoietic And Lymphoid Tissues CD19 Clinical Medicine Immune System Immunology Acute Myeloid Leukemia Biology Blastoma Cancer Immunotherapy Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Health Sciences Hematopoietic Stem Cell
        Hematologic Malignancies

        Hematologic malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematologic malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for hematologic malignancies may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

        Browse All Tags